Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

June 12, 2020

Primary Completion Date

November 19, 2022

Study Completion Date

November 19, 2022

Conditions
Seborrheic Dermatitis
Interventions
DRUG

ARQ-154

ARQ-154 foam 0.3% applied once daily for 52 weeks

Trial Locations (39)

10029

Arcutis Biotherapeutics Clinical Site 55, New York

10462

Arcutis Biotherapeutics Clinical Site 63, The Bronx

15213

Arcutis Biotherapeutics Clinical Site 27, Pittsburgh

20850

Arcutis Biotherapeutics Clinical Site 28, Rockville

23502

Arcutis Biotherapeutics Clinical Site 17, Norfolk

27262

Arcutis Biotherapeutics Clinical Site 23, High Point

29407

Arcutis Biotherapeutics Clinical Site 76, Charleston

32771

Arcutis Biotherapeutics Clinical Site 65, Sanford

33134

Arcutis Biotherapeutics Clinical Site 42, Coral Gables

33144

Arcutis Biotherapeutics Clinical Site 24, Miami

33180

Arcutis Biotherapeutics Clinical Site 53, Aventura

33484

Arcutis Biotherapeutics Clinical Site 57, Delray Beach

33613

Arcutis Biotherapeutics Clinical Site 12, Tampa

40217

Arcutis Biotherapeutics Clinical Site 15, Louisville

43209

Arcutis Biotherapeutics Clinical Site 18, Bexley

46168

Arcutis Biotherapeutics Clinical Site 22, Plainfield

48038

Arcutis Biotherapeutics Clinical Site 40, Clinton Township

48059

Arcutis Biotherapeutics Clinical Site 58, Fort Gratiot

48202

Arcutis Biotherapeutics Clinical Site 20, Detroit

55432

Arcutis Biotherapeutics Clinical Site 14, Fridley

60008

Arcutis Biotherapeutics Clinical Site 10, Rolling Meadows

70006

Arcutis Biotherapeutics Clinical Site 52, Metairie

76011

Arcutis Biotherapeutics Clinical Site 13, Arlington

77056

Arcutis Biotherapeutics Clinical Site 25, Houston

77845

Arcutis Biotherapeutics Clinical Site 41, College Station

78213

Arcutis Biotherapeutics Clinical Site 54, San Antonio

78660

Arcutis Biotherapeutics Clinical Site 26, Pflugerville

78759

Arcutis Biotherapeutics Clinical Site 11, Austin

89148

Arcutis Biotherapeutics Clinical Site 50, Las Vegas

90036

Arcutis Biotherapeutics Clinical Site 62, Los Angeles

90212

Arcutis Biotherapeutics Clinical Site 59, Beverly Hills

90404

Arcutis Biotherapeutics Clinical Site 21, Santa Monica

91436

Arcutis Biotherapeutics Clinical Site 51, Encino

92123

Arcutis Biotherapeutics Clinical Site 64, San Diego

92708

Arcutis Biotherapeutics Clinical Site 75, Fountain Valley

94538

Arcutis Biotherapeutics Clinical Site 19, Fremont

97210

Arcutis Biotherapeutics Clinical Site 29, Portland

02135

Arcutis Biotherapeutics Clinical Site 73, Brighton

03801

Arcutis Biotherapeutics Clinical Site 56, Portsmouth

Sponsors
All Listed Sponsors
lead

Arcutis Biotherapeutics, Inc.

INDUSTRY